{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-082319","form_type":"8-K","ticker":"WOOF","cik":"0001826470","company_name":"Petco Health & Wellness Company, Inc.","filed_at":"2025-06-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.964279+00:00","generated_at":"2026-05-19T22:36:42.800287+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Petco Q1 net sales down 2.3% to $1.5B; net loss improves to $11.7M; reaffirms FY2025 outlook","bullets":["Net sales $1.5B, down 2.3% YoY; comparable sales -1.3%; gross margin +30bps to 38.2%.","Operating income improved $33.1M to $16.4M; GAAP net loss improved $34.8M to $11.7M.","Adjusted EBITDA rose $13.8M to $89.4M, ahead of guidance.","Q2 2025 outlook: net sales down low single digits YoY; Adj. EBITDA $92-$94M.","FY2025 outlook reaffirmed: Adj. EBITDA $375-$390M; capex $125-$130M; assumes tariffs at current levels."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-082319","json":"https://secwatch.observer/filing/0000950170-25-082319.json","markdown":"https://secwatch.observer/filing/0000950170-25-082319.md","text":"https://secwatch.observer/filing/0000950170-25-082319.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1826470/000095017025082319/0000950170-25-082319-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1826470/000095017025082319/woof-20250605.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T22:36:42.800287+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}